Human Biotechnology: Responding to Emerging Dangerous New Human Genetics
By Jesse Reynolds,
Z Magazine
| 03. 31. 2003
As 2003 began, the mainstream press was grappling with a cloning hoax. This January, it launched extended coverage of the 50th anniversary of the identification of DNA's structure. Both events provided golden opportunities to deepen public understanding of the social and political implications of new human genetic and reproductive technologies.
Unfortunately, the media have mostly flubbed these opportunities. The coverage of the Raelians' cloning claims obscured rather than illuminated the critical issues. Early signs on the second media opportunity-a series of carefully planned celebrations throughout the spring-are none too promising. Fortunately, a civil society response to dangerous new human genetic and reproductive technologies is emerging in a number of countries, as witnessed at January's World Social Forum in Brazil.
The year's first human biotechnology media frenzy actually began at the end of December 2002, when a previously obscure alien-chasing sect announced that its scientists had produced the world's first human clone. The initial news reaction appropriately focused on whether the claim could be true. But by the time the Raelians' excuses as to why they were unable to show the...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Tina Stevens, CounterPunch | 12.11.2025
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI mogul Sam Altman, cryptocurrency entrepreneur Brian Armstrong, venture capitalist Peter...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...